Vonoprazan Study of Investigating the Effect on Sleep Disturbance Associated With Reflux Esophagitis- Exploratory Evaluation (VISTAEXE)
Phase of Trial: Phase IV
Latest Information Update: 22 Jan 2018
At a glance
- Drugs Vonoprazan (Primary)
- Indications Reflux oesophagitis
- Focus Therapeutic Use
- Acronyms VISTAEXE
- Sponsors Takeda
- 31 Aug 2018 Biomarkers information updated
- 16 Jan 2018 Status changed from active, no longer recruiting to completed.
- 28 Nov 2017 Status changed from recruiting to active, no longer recruiting.